Alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: A preliminary report of phase II study

Radiotherapy and Oncology

Volumn 61, Issue 3, 2001, Pages 257-260

  Fuwa, Nobukazu ^a   Kano, Makoto ^b   Toita, Takafuni ^c   Shikama, Naoto ^d   Kodaira, Takeshi ^a   Matsumoto, Akira ^a   Kamata, Minoru ^a   Furutani, Kazuhisa ^a   Tatibana, Hiroyuki ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

^d SHINSHU UNIVERSITY   (Japan)

Author keywords

5 fluorouracil; Alternating chemoradiotherapy; Cisplatin; Nasopharyngeal cancer; Radiotherapy

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; GRANISETRON; ONDANSETRON; STEROID;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL RATE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 0035197853     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(01)00422-4     Document Type: Article

References (9)

1. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 0099
2. Prospective randomized trial conducted to compare chemo-radiotherapy against radiotherapy alone in the treatment of loco regionally advanced nasopharyngeal carcinoma
3. Preliminary report of the the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with local-regionally advanced nasopharyngeal carcinoma
4. Preliminary results of randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (∼N2, MO) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival
5. Nonparametric estimations from incomplete observations
6. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy
7. Poorly differentiated naso-and oropharyngeal carcinoma